Literature DB >> 9829591

Biodistribution and kinetics of nasal carbon-11-triamcinolone acetonide.

M S Berridge1, D L Heald, G J Muswick, G P Leisure, K W Voelker, F Miraldi.   

Abstract

UNLABELLED: PET is a technique with a strong potential for use in drug evaluation and development. In particular, the distribution and pharmacokinetics of locally administered drugs may be advantageously explored noninvasively using labeled compounds. This pilot study was performed to demonstrate the effectiveness of PET for drug development and to determine the human biodistribution and kinetics of triamcinolone acetonide, labeled with 11C, formulated and nasally administered as Nasacort AQ nasal inhalant.
METHODS: Carbon-11-labeled triamcinolone acetonide was formulated as the commercial product, and PET scans of the heads of four volunteers were performed in a vertical orientation. Region-of-interest analysis with MRI coregistration was used to analyze the distribution and kinetics in nasal tissues.
RESULTS: Deposition of the majority of the dose on target tissues was immediate. Penetration into sinuses was observed. There was moderate redistribution and slow migration of the drug through nasal passages to the throat. Significant amounts of the drug remained in target regions for several hours.
CONCLUSION: PET is an effective means to determine local drug distribution and kinetics.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9829591

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  4 in total

1.  Septoplasty and decongestant improve distribution of nasal spray.

Authors:  Jiaoping Mi; Yunping Fan; Shaoyan Feng; Wentong Xia; Jingqing Wang; Huabin Li
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-12-16

2.  Smoking produces rapid rise of [11C]nicotine in human brain.

Authors:  Marc S Berridge; Scott M Apana; Kenichi K Nagano; Catherine E Berridge; Gregory P Leisure; Mark V Boswell
Journal:  Psychopharmacology (Berl)       Date:  2010-03-16       Impact factor: 4.530

3.  Triamcinolone Acetonide in the Treatment of Perennial Allergic Rhinitis: A post hoc Efficacy Analysis of a Phase III Study Performed in Russia.

Authors:  Alexander V Karaulov; Natalia I Ilina; Natalia Shartanova; Aleksandr Maslakov; Luiz Lucio
Journal:  Int Arch Allergy Immunol       Date:  2021-09-14       Impact factor: 2.749

4.  Patient preference and sensory perception of three intranasal corticosteroids for allergic rhinitis.

Authors:  Chaweewan Bunnag; Dr Suprihati; De-Yun Wang
Journal:  Clin Drug Investig       Date:  2003       Impact factor: 2.859

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.